HRP20150228T1 - Novi analozi piperazina kao antivirusna sredstva širokog spektra protiv virusa gripe - Google Patents

Novi analozi piperazina kao antivirusna sredstva širokog spektra protiv virusa gripe

Info

Publication number
HRP20150228T1
HRP20150228T1 HRP20150228AT HRP20150228T HRP20150228T1 HR P20150228 T1 HRP20150228 T1 HR P20150228T1 HR P20150228A T HRP20150228A T HR P20150228AT HR P20150228 T HRP20150228 T HR P20150228T HR P20150228 T1 HRP20150228 T1 HR P20150228T1
Authority
HR
Croatia
Prior art keywords
broad
novel piperazine
spectrum influenza
influenza antivirals
piperazine analogs
Prior art date
Application number
HRP20150228AT
Other languages
English (en)
Inventor
Christopher W. Cianci
Samuel Gerritz
Guo Li
Bradley C. Pearce
Annapurna Pendri
Shuhao Shi
Weixu Zhai
Shirong Zhu
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of HRP20150228T1 publication Critical patent/HRP20150228T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
HRP20150228AT 2010-09-08 2015-02-26 Novi analozi piperazina kao antivirusna sredstva širokog spektra protiv virusa gripe HRP20150228T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38072810P 2010-09-08 2010-09-08
EP11758034.0A EP2614052B1 (en) 2010-09-08 2011-09-06 Novel piperazine analogs as broad-spectrum influenza antivirals
PCT/US2011/050504 WO2012033736A1 (en) 2010-09-08 2011-09-06 Novel piperazine analogs as broad-spectrum influenza antivirals

Publications (1)

Publication Number Publication Date
HRP20150228T1 true HRP20150228T1 (hr) 2015-04-10

Family

ID=44653573

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20150228AT HRP20150228T1 (hr) 2010-09-08 2015-02-26 Novi analozi piperazina kao antivirusna sredstva širokog spektra protiv virusa gripe

Country Status (17)

Country Link
US (1) US8362004B2 (hr)
EP (1) EP2614052B1 (hr)
JP (1) JP5902172B2 (hr)
CN (1) CN103201268B (hr)
BR (1) BR112013005552A2 (hr)
CA (1) CA2809624A1 (hr)
DK (1) DK2614052T3 (hr)
EA (1) EA023258B1 (hr)
ES (1) ES2533068T3 (hr)
HR (1) HRP20150228T1 (hr)
MX (1) MX2013002557A (hr)
PL (1) PL2614052T3 (hr)
PT (1) PT2614052E (hr)
RS (1) RS53844B1 (hr)
SI (1) SI2614052T1 (hr)
SM (1) SMT201500068B (hr)
WO (1) WO2012033736A1 (hr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
CN105101959B (zh) * 2012-11-05 2018-04-17 南特知识产权控股有限责任公司 作为刺猬信号传导通路的抑制剂的含有环状磺酰胺的衍生物
KR102089122B1 (ko) * 2016-08-25 2020-03-13 주식회사 엘지화학 디아민 화합물 및 이를 이용하여 제조된 플렉시블 소자용 기판
US11040963B2 (en) 2017-02-02 2021-06-22 Janssen Vaccines & Prevention B.V. Piperazine derivatives for influenza virus inhibitions
WO2018141854A1 (en) 2017-02-02 2018-08-09 Janssen Vaccines & Prevention B.V. Piperazine derivatives for influenza virus inhibition
WO2021204923A1 (en) * 2020-04-09 2021-10-14 Vironova Medical Ab Antiviral agents
WO2021204924A1 (en) * 2020-04-09 2021-10-14 Vironova Medical Ab Compounds for use in the treatment of hypercytokinemia

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914371D0 (en) * 1999-06-18 1999-08-18 Smithkline Beecham Plc Novel compounds
KR20040010713A (ko) * 2001-06-15 2004-01-31 야마노우치세이야쿠 가부시키가이샤 페닐피리딘 카보닐 피페라진 유도체
AU2003246972A1 (en) 2002-08-06 2004-02-23 Astrazeneca Ab Condensed pyridines and pyrimidines with tie2 (tek) activity
WO2004078732A1 (fr) 2003-01-28 2004-09-16 Aventis Pharma S.A. Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
US6949865B2 (en) * 2003-01-31 2005-09-27 Betabatt, Inc. Apparatus and method for generating electrical current from the nuclear decay process of a radioactive material
GB0428235D0 (en) 2004-12-23 2005-01-26 Glaxo Group Ltd Novel compounds
EP1834954A1 (en) * 2006-03-15 2007-09-19 4Sc Ag Thiazoles as NF-kB Inhibitors (proteasome inhibitors)
AU2010281265A1 (en) * 2009-08-05 2012-03-22 Versitech Limited Antiviral compounds and methods of making and using thereof

Also Published As

Publication number Publication date
PT2614052E (pt) 2015-03-31
PL2614052T3 (pl) 2015-06-30
SMT201500068B (it) 2015-05-05
WO2012033736A1 (en) 2012-03-15
US20120238539A1 (en) 2012-09-20
CN103201268B (zh) 2015-08-12
BR112013005552A2 (pt) 2016-05-03
EP2614052B1 (en) 2014-12-31
SI2614052T1 (sl) 2015-04-30
EP2614052A1 (en) 2013-07-17
DK2614052T3 (en) 2015-04-07
ES2533068T3 (es) 2015-04-07
RS53844B1 (en) 2015-08-31
CN103201268A (zh) 2013-07-10
JP2013537193A (ja) 2013-09-30
JP5902172B2 (ja) 2016-04-13
US8362004B2 (en) 2013-01-29
EA023258B1 (ru) 2016-05-31
CA2809624A1 (en) 2012-03-15
EA201390362A1 (ru) 2013-07-30
MX2013002557A (es) 2013-05-28

Similar Documents

Publication Publication Date Title
HK1206339A1 (en) N-aryltriazole compounds as lpar antagonists lpar n-
HK1206342A1 (en) N-alkyltriazole compounds as lpar antagonists lpar n-
AP3391A (en) 2-Amino-4-arylthiazole compounds as TROA1 antagonists
GB201106799D0 (en) Novel compounds
GB201107325D0 (en) Novel compounds
GB201112607D0 (en) Novel compounds
HRP20150228T1 (hr) Novi analozi piperazina kao antivirusna sredstva širokog spektra protiv virusa gripe
ZA201309245B (en) Novel fluoroergoline analogs
GB201111704D0 (en) Novel compounds
EP2717694A4 (en) NEW COMPOUNDS
EP2681198A4 (en) NEW LITTLE MOLECULES AS THERAPIES
HK1189880A1 (en) Benzodioxole piperazine compounds
HK1176061A1 (en) Novel benzamide derivatives
FR2967164B1 (fr) Procede de preparation de compositions a base de polypentosides
EP2727594A4 (en) NEW PHARMACEUTICAL COMPOSITION
IL223324A0 (en) Novel pharmaceutical compounds
GB201105224D0 (en) Novel pharmaceutical compositions
GB201113448D0 (en) Novel compounds 61
GB201113443D0 (en) Novel compounds 62
GB201113441D0 (en) Novel compounds 64
GB201113450D0 (en) Novel compounds 60
GB201103075D0 (en) Novel compounds 3
GB201103074D0 (en) Novel compounds 1
GB201101824D0 (en) Novel heteroclyclic compounds 5
GB201113757D0 (en) Novel compounds